谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

AdvanTIG-202: Phase 2 Open-Label, Two-Cohort Multicenter Study of Ociperlimab Plus Tislelizumab and Tislelizumab Alone in Patients with Previously Treated Recurrent or Metastatic Cervical Cancer.

Jung-Yun Lee, Sathana Boonyapipat,Guangwen Yuan,Hee Seung Kim,Jeong-Won Lee,Li Wang,Tao Wang,Danbo Wang,Desheng Yao, Hu Liu,Chih-Long Chang, Timur Turdeevich Andabekov,Xiang Zhang, Wei Wang, Yong Man Kim, Ivan Volodymyrovych Sinielnikov, Kai Wang, Yujuan Gao, Xiyan Mu,Lingying Wu

Gynecologic oncology（2025）

引用 0|浏览0
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要